Brown Brothers Harriman & Co’s Bausch Health BHC Stock Holding History

Brown Brothers Harriman & Co’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,600	Closed	-$101K	–	1851
2025 Q3	$101K	Hold	15,600	–	–	﹤0.01%	867
2025 Q2	$104K	Hold	15,600	–	–	﹤0.01%	778
2025 Q1	$101K	Hold	15,600	–	–	﹤0.01%	697
2024 Q4	$126K	Hold	15,600	–	–	﹤0.01%	678
2024 Q3	$127K	Hold	15,600	–	–	﹤0.01%	652
2024 Q2	$109K	Buy	+15,600	New	+$118K	﹤0.01%	643
2023 Q4	–	Sell	-33,357	Closed	-$274K	–	1163
2023 Q3	$274K	Buy	33,357 +30,890	+1,252%	+$266K	﹤0.01%	429
2023 Q2	$19.7K	Buy	+2,467	New	+$18.2K	﹤0.01%	867
2022 Q3	–	Sell	-30,000	Closed	-$251K	–	1506
2022 Q2	$251K	Hold	30,000	–	–	﹤0.01%	426
2022 Q1	$686K	Hold	30,000	–	–	﹤0.01%	302
2021 Q4	$828K	Hold	30,000	–	–	﹤0.01%	267
2021 Q3	$836K	Hold	30,000	–	–	﹤0.01%	256
2021 Q2	$880K	Hold	30,000	–	–	0.01%	247
2021 Q1	$952K	Hold	30,000	–	–	0.01%	227
2020 Q4	$624K	Hold	30,000	–	–	﹤0.01%	270
2020 Q3	$466K	Hold	30,000	–	–	﹤0.01%	274
2020 Q2	$549K	Hold	30,000	–	–	﹤0.01%	255
2020 Q1	$465K	Hold	30,000	–	–	﹤0.01%	260
2019 Q4	$898K	Hold	30,000	–	–	0.01%	250
2019 Q3	$656K	Hold	30,000	–	–	﹤0.01%	263
2019 Q2	$757K	Hold	30,000	–	–	0.01%	237
2019 Q1	$741K	Hold	30,000	–	–	0.01%	225
2018 Q4	$554K	Hold	30,000	–	–	﹤0.01%	237
2018 Q3	$770K	Hold	30,000	–	–	﹤0.01%	217
2018 Q2	$697K	Hold	30,000	–	–	﹤0.01%	208
2018 Q1	$478K	Hold	30,000	–	–	﹤0.01%	244
2017 Q4	$623K	Hold	30,000	–	–	﹤0.01%	226
2017 Q3	$430K	Hold	30,000	–	–	﹤0.01%	244
2017 Q2	$519K	Hold	30,000	–	–	﹤0.01%	223
2017 Q1	$331K	Buy	30,000 +29,000	+2,900%	+$399K	﹤0.01%	268
2016 Q4	$15K	Buy	+1,000	New	+$18.3K	﹤0.01%	655
2016 Q2	–	Sell	-20,404	Closed	-$537K	–	831
2016 Q1	$537K	Buy	20,404 +3,416	+20%	+$253K	﹤0.01%	221
2015 Q4	$1.73M	Buy	16,988 +5,356	+46%	+$602K	0.01%	151
2015 Q3	$2.08M	Buy	11,632 +1,106	+11%	+$258K	0.01%	146
2015 Q2	$2.34M	Hold	10,526	–	–	0.01%	138
2015 Q1	$2.09M	Buy	+10,526	New	+$1.87M	0.01%	145
2014 Q3	–	Sell	-260	Closed	-$33K	–	758
2014 Q2	$33K	Hold	260	–	–	﹤0.01%	560
2014 Q1	$34K	Buy	+260	New	+$35.5K	﹤0.01%	547

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brown Brothers Harriman & Co's BHC Position: Q4 2025 in Review

Brown Brothers Harriman & Co sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 15,600 shares — an estimated $101K sold.

Brown Brothers Harriman & Co first reported a position in BHC in Q1 2014 and held it in 38 quarters. The position peaked at $2.34M in Q2 2015. 236 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

Brown Brothers Harriman & Co reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
Brown Brothers Harriman & Co sold 15,600 Bausch Health shares in Q4 2025, an estimated $101K.
Brown Brothers Harriman & Co first reported a position in Bausch Health in Q1 2014 and held it in 38 quarters.
Brown Brothers Harriman & Co's Bausch Health position peaked at $2.34M in Q2 2015.
236 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2025, filed 12 Feb 2026.